General presentation Luxembourg BioHealth Cluster

Overview of the Luxembourg BioHealth Cluster

Luxembourg BioHealth Cluster

Dr. Thomas DentzerLuxembourg BioHealth Cluster Manager

Luxembourg – June 2013

Luxembourg BioHealth Cluster| June 2013

Area 2,586 km2

Population ~ 500,000(42 % foreigners)

Languages Luxembourgish, German, French, English

Political System Constitutional MonarchyParliamentary DemocracyFounding member of the European Union, United Nations, Benelux

2

Luxembourg – the country


Luxembourg invests in Biohealth

Why Biohealth?

• Economic diversification• Becoming the healthiest country, one person at a time


Strategy – political commitment

Launch of Governmental Initiative in 2008 (140 M€ in 5 years) to develop inLuxembourg a Centre of excellence in molecular diagnostics, cornerstone of

personalised medicine.

Vision• Active role in future healthcare challenges• Invest in a knowledge-based, sustainable sector• Sustainable healthcare services for Luxembourg

Key mission of the Grand Duchy• Boost and foster R&D activities• Encourage technical and scientific cooperation as well as technology transfer between the

public and private sector• Focus on molecular medicine and molecular diagnosis for the purpose of transforming the

healthcare systems for people of Luxembourg and for promoting economic growth in biotechnology


Recent evolution of life science centers

20002000

New governmental strategy directed to develop biomedical

sciences

Numerous private life sciences companies in various fields have chosen Luxembourg as base for their activities or as

European headquarters.

Ongoing investments contribute to a flourishing life science environment in constant evolution an expansion in both the public and private sector.

Since 2000, Luxembourg has multiplied its public expenditure on public research by ten with an ultimate goal of 1% of

GDP, added to the nearly 1.4% of GDP invested in R&D by private companies.


Private

Public R&D

Public - Institutionals

Hospitals

Luxembourg map of key actors


The Luxembourg Cluster Initiative


Luxinnovation

Information & guidance on

suitable funding

mechanisms

Assistance with the

preparation of applications & endorsement

towards public decision-makers

ACCES TO NATIONAL & EUROPEAN

FUNDING

SUPPORT FOR THE CREATION

OF INNOVATIVE BUSINESSES

INNOVATION MANAGE-

MENT, DESIGN, CREATIVITY

TECHNOLOGY TRANSFER &

PARTNER SEARCH

INTELLECTUAL PROPERTY &

VALORISATION OF RESEARCH

RESULTS

LUXEMBOURG CLUSTER

INITIATIVE

PROMOTION OF RESEARCH

& INNOVATION “MADE IN

LUXEMBOURG”

Analysis of the underlying idea

and business plan, access to

national business

incubators

Identification of prospective

partners, sourcing of

financial support

Comprehensive training

programmes

Luxembourg Innovation

Master Class

Promotion of design &

creativity in support of innovation

Access to the Technology

Market of the Enterprise

Europe Network

Identification of potential partners &

contract initiation

Awareness-raising

activities and guidance on intellectual

property

Coaching for the socio-economic

valorisation of research results

Animation of the BioHealth, EcoInnovation, ICT, Materials

and Space clusters

Support for project

construction in view of PPP

Events

Communica-tion tools

Luxembourg Portal for

Innovation and Research

Focus on Research and Innovation in Luxembourg


The Luxembourg BioHealth Cluster

Vision

Luxembourg, a well recognised location to develop Healthcare Biotech RDI activitieswith a sustainable healthcare system

Mission

Contribute to building in Luxembourg a successful ecosystem that will attract and retain biotech companies and laboratories


13 New Members since July 2012

10

• Office Freylinger• Novartis Pharma (CH)• go4labs (DE)• Association pharmaceutique luxembourgeoise / APL• WaferGen Biosystems Europe s.àr.l.• Biotech-Industry• Fédération des Hôpitaux luxembourgeois• Huggard Consulting Group• BIL• Intelligentsia Consultants• T&E Gefahrgutlogistik S.A.• House of Biohealth• Montrium Europe s.àr.l.

49 total memberso 27 companieso 11 service providerso 7 public research

organisationso 4 strategic partners

The Luxembourg BioHealth Cluster – Recent Developments


Objective 1: Accelerate innovation

Key factors behind success:

• Strong scientific base• Availability of venture and seed capital• Strong supporting Infrastructures: House of BioHealth • Industrial base and Interaction between research and industry

Main objectives

House of BioHealth


Main objectives

Objective 2: Creating a Luxembourg Biohealth brand

Key actions:

• Development of the brand in collaboration with other actors• Promotion and representation (conferences, fairs, trade shows)• Organisation of events (networking events, conferences, fairs, trade shows)


Objective 3: Support national and international relationships

Provide added-value services/support actions to members:

• Information on technological and market context of their activities; events; funding opportunities at national and international level

• Specific support from idea to project: identification of funding resources, partners,…

Main objectives


Examples of public players

Founded in 2009, Director Prof. Rudi Balling Centre of excellence in systems biology: Genomics, Metabolomics,

Bioinformactics Focus on neurodegenerative diseases, especially Parkinson’s

disease and on diabetes type II and life-style related diseases

Opened in Febuary 2010, CEO Dr Catherine Larue Activities in Biospecimen collection and Biorepository, Sample

analysis (molecular biology, genomic, immunological and cellular assays), Data storage and pseudonomisation by thrusted third party

Thriving to become an international centre of excellence for biobanking, a leader in biospecimen research and a partner in the introduction of personalized medical care in Luxembourg

Founded in 1989, CEO Dr Jean-Claude Schmit Active in basic, pre-clinical and clinical research in life sciences 5 Research Departments, 3 competence centers and several

platforms


Examples of private players

WaferGen Biosystems is a provider of a SmartChip Real-Time PCR System platform for biomarker identification and validation

It has a partnership with IBBL which has purchased a machine and offers support to perform Fee For Service for Wafergen’s EU clients

Founded in 1987, new production site opened in 2011 Cellon is a manufacturer of cell culture systems :3D cell culture,

vaccine production systems, rotary systems

Founded in 2006, as a spin off of a medical diagnostics lab Fast-track diagnostics develops multiplex RT-PCR kits for infectious

diseases with a syndromic approach


Personalized Medicine Consortium (PMC)

• Cancer (Breast, colon and lung)• Neurodegenrative diseases, especially Parkinson• Diabetes and life-style related diseases• Normal population cohort


Future orientations

Main Focus in 2013

• Internationalisation of the Cluster

• Increased promotion of cluster members

• National biomedical sector branding

• Development and management of Life Sciences and Healthcare projects


Selected upcoming Events

•2nd International Systems Biomedicine Symposium 2013 21-22 October 2013

•Clinical Research Day - Fifth Edition 23 October 2013

•2nd annual Health Economics and Personalised Medicine Symposium 28-29 October 2013

•Hospital management in times of crisis 28-30 November 2013

•Medica Duesseldorf20-23 November 2013


Jean-Paul ScheurenLuxembourg BioHealth Cluster President

Thomas Dentzer, PhDLuxembourg BioHealth Cluster Manager

[email protected]

Luxembourg BioHealth Cluster

7, rue Alcide de Gasperi L-1615 Luxembourg

Tel: +352 43 62 63 - 1

www.biohealthcluster.lu

Groups / Luxembourg BioHealth Cluster

Twitter: @LuxBioHealth

Follow us on Social Media